Phenotypic variations between a fat-preferring strain and a macronutrient non-preferring strain of mouse

Diabetes, Obesity & Metabolism
Timothy South, X-F Huang

Abstract

This study aims to establish a model that will allow the comparison of the phenotypic variations between a fat-preferring strain and a macronutrient non-preferring strain of mouse. Five strains (AKR, A/J, ARC, C57Bl/6 and BALB/c) were fed a two-choice diet (high-fat/low-carbohydrate and low-fat/high-carbohydrate) for 30 days. Following completion of the 30-day feeding period, the brains of the fat-preferring and macronutrient non-preferring mice were removed for the analysis of the expression of the genes - agouti-related peptide (AgRP) and pro-opiomelanocortin (POMC). Upon completion of the experiment, it was found that the C57Bl/6 strain was the strongest fat preferrer consuming 72% of their calories from the high-fat diet, whereas the BALB/c was found to have no macronutrient preference. Using in situ hybridization techniques, no significant differences in the expression of POMC were found between the two strains. It was, however, showed that the BALB/c mice had a 33.7% higher expression level of AgRP than the C57Bl/6 mice. The lower expression level of AgRP in the C57Bl/6 mice may be suggestive of a defensive response to their chronic preferential consumption of the high-fat diet. However, the wide variety of neuroregulator...Continue Reading

References

Feb 1, 1995·Journal of Epidemiology and Community Health·D H GathS A Bond
Apr 1, 1995·The American Journal of Physiology·C N BoozerR L Atkinson
May 1, 1995·Metabolism: Clinical and Experimental·R S SurwitM Rebuffé-Scrive
Jan 22, 1998·The American Journal of Physiology·M J GlassA S Levine
Mar 5, 1998·The American Journal of Physiology·B E Levin, R E Keesey
Jun 20, 1998·Science·J O Hill, J C Peters
Jun 5, 1998·The American Journal of Physiology·J WangS F Leibowitz
Jul 17, 1999·The American Journal of Physiology·M Covasa, R C Ritter
Nov 24, 1999·The American Journal of Physiology·M J GlassA S Levine
Dec 22, 1999·Physiology & Behavior·F H KoeglerG A Bray
Dec 30, 1999·Science·S FultonP Shizgal
Jan 25, 2000·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·B E Levin, A A Dunn-Meynell
Apr 6, 2000·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·B K SmithD B West
Jun 13, 2000·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·S LinX F Huang
Mar 10, 2001·Recent Progress in Hormone Research·S Collins, R S Surwit
Dec 18, 2001·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Barry E Levin, Ambrose A Dunn-Meynell
Dec 26, 2001·Neuropharmacology·M OdorizziA Burlet
Mar 29, 2002·Diabetes Care·Zachary T Bloomgarden
Apr 23, 2002·Nature Reviews. Neuroscience·Jan G Bjaalie
Jun 8, 2002·Science·Ellen E PaxinosRobert C Fleischer
Feb 8, 2003·Science·Jean Marx
Feb 8, 2003·Science·James O HillJohn C Peters
Apr 11, 2003·Regulatory Peptides·Philippe SamamaJoseph F Grippo
Apr 29, 2004·The American Journal of Clinical Nutrition·Andrea C Buchholz, Dale A Schoeller
Jun 4, 2004·Behavioral Neuroscience·Dianne P FiglewiczStephen C Benoit
Jun 26, 2004·BMJ : British Medical Journal·Mickey Chopra, Ian Darnton-Hill

❮ Previous
Next ❯

Citations

May 15, 2012·European Journal of Lipid Science and Technology : EJLST·Ying GuoHao Zhu
Sep 25, 2021·Biomédica : revista del Instituto Nacional de Salud·Jorge Alberto EscotoRoxana Valdés-Ramos
Oct 18, 2007·Current Opinion in Endocrinology, Diabetes, and Obesity

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.